New Zealand markets open in 4 hours 35 minutes

Insulet Corporation (PODD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
204.21+0.11 (+0.05%)
As of 01:25PM EDT. Market open.

Insulet Corporation

100 Nagog Park
Acton, MA 01720
United States
978 600 7000
https://www.insulet.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees3,000

Description

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Corporate governance

Insulet Corporation’s ISS governance QualityScore as of 1 June 2024 is 9. The pillar scores are Audit: 6; Board: 7; Shareholder rights: 10; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.